Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001662579-23-000097

Chief Financial Officer acquired 25,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Adams Kendra Chief Financial Officer 2023-09-18 Grant or award +25,000 46,640 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Adams Kendra Chief Financial Officer 2023-09-18 Grant or award · Stock Option (Right to Buy) +111,000 111,000 D: show line 2 in the form
Loading xslF345X05/wk-form4_1695165671.xml…